Jounce Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2016 to Q4 2022

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Jounce Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2016 to Q4 2022.
  • Jounce Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2022 was 51.7M shares, a 3.5% increase year-over-year.
  • Jounce Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 51.7M shares, a 3.5% increase from 2021.
  • Jounce Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 49.9M shares, a 40.9% increase from 2020.
  • Jounce Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 35.4M shares, a 7.09% increase from 2019.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 51.7M +1.75M +3.5% Oct 1, 2022 Dec 31, 2022 10-K/A 2023-04-28
Q3 2022 51.7M +462K +0.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 51.7M +466K +0.91% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 51.6M +5.68M +12.3% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 49.9M Oct 1, 2021 Dec 31, 2021 10-K/A 2023-04-28
Q3 2021 51.2M +17.1M +50% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 51.2M +17.2M +50.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 46M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 34.2M +1.05M +3.16% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 34.1M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q3 2019 33.1M +471K +1.44% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q3 2018 32.6M +459K +1.43% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q3 2017 32.2M +30.1M +1410% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-13
Q3 2016 2.13M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.